Theorem Clinical Research

Awards & Advancement

Quest Diagnostics names Franklin R. Cockerill VP, chief laboratory officer

Thursday, October 9, 2014 11:10 AM

Quest Diagnostics, a provider of diagnostic information services, has announced that Franklin R. Cockerill, III, M.D., has joined the company as vice president and chief laboratory officer, effective Oct. 1.

More... »

Quest Diagnostics

Formex expands services, adds scientific staff and equipment

Thursday, October 9, 2014 08:27 AM

Formex, a pharmaceutical formulation developer and manufacturer, has expanded both scientific personnel and equipment.

More... »


WIRB-Copernicus Group appoints Lindsay McNair chief medical officer

Friday, October 3, 2014 08:29 AM

WIRB-Copernicus Group (WCG), a provider of regulatory and ethical review services and software to support clinical research, has promoted Lindsay McNair, M.D., M.P.H., M.S.B., to chief medical officer.

More... »

BioClinica Compass wins technology innovation award

Thursday, October 2, 2014 01:32 PM

BioClinica, a provider of outsourced clinical trial services and eClinical Solutions, has announced that its Compass technology, a risk-based monitoring solution that improves overall quality in clinical trials, has won the inaugural Society for Clinical Data Management (SCDM) NextGen Technology Innovation (TIA) Award, presented as part of SCDM's 2014 annual conference.

More... »

Zynerba Pharmaceuticals expands management team

Thursday, October 2, 2014 01:30 PM

Zynerba Pharmaceuticals, a specialty pharmaceutical company dedicated to the development of innovative transdermal cannabinoid treatments, has named three seasoned pharmaceutical executives to its management team. Donna Gutterman, PharmD, is a consultant who will be vice president, medical affairs; Carol O'Neill will be vice president, development; and Suzanne Hanlon will be general counsel and vice president, human resources.

More... »

Mast Therapeutics appoints Edwin L. Parsley chief medical officer

Thursday, October 2, 2014 01:21 PM

Mast Therapeutics, a clinical-stage biopharmaceutical company, has announced that Edwin L. Parsley, D.O., has joined the company as its chief medical officer and senior vice president.

More... »

BioLife Solutions adds Jason Acker, Anthony Davies to scientific advisory board

Thursday, September 25, 2014 03:00 PM

BioLife Solutions, a developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, has hired two new additions to its scientific advisory board. The new members are Jason Acker, Ph.D., and Anthony Davies, Ph.D.

More... »

Highland Therapeutics appoints Dr. Floyd R. Sallee chief medical officer

Thursday, September 25, 2014 02:29 PM

Highland Therapeutics has appointed Dr. Floyd R. Sallee as chief medical officer of Ironshore Pharmaceuticals & Development, Highland's wholly owned principal operating subsidiary.

More... »

GlaxoSmithKline appoints Sir Philip Hampton to the board of directors

Thursday, September 25, 2014 02:06 PM

GlaxoSmithKline has announced that Sir Philip Hampton will join the board of the company as non-executive director January 2015 and will become deputy chairman effective April 2015. He will succeed Sir Christopher Gent.

More... »

Delphinus appoints Mark J. Forchette president and CEO

Thursday, September 18, 2014 02:36 PM

Delphinus Medical Technologies, a Michigan developer of SoftVue, a whole breast ultrasound system that incorporates a ring transducer design, has named Mark J. Forchette president and CEO.

More... »

AiCure
CWWeekly

March 30

Icon, Carnegie Mellon partner to research ways to improve study patients' understanding of Informed Consent

Veeva launches OpenKey, partner program to unlock difficult access to, restrictions on customer reference data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs